Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does KANAMYCIN\KANAMYCIN A Cause Neuropathy peripheral? 18 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neuropathy peripheral have been filed in association with KANAMYCIN\KANAMYCIN A. This represents 11.5% of all adverse event reports for KANAMYCIN\KANAMYCIN A.

18
Reports of Neuropathy peripheral with KANAMYCIN\KANAMYCIN A
11.5%
of all KANAMYCIN\KANAMYCIN A reports
7
Deaths
7
Hospitalizations

How Dangerous Is Neuropathy peripheral From KANAMYCIN\KANAMYCIN A?

Of the 18 reports, 7 (38.9%) resulted in death, 7 (38.9%) required hospitalization, and 3 (16.7%) were considered life-threatening.

Is Neuropathy peripheral Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for KANAMYCIN\KANAMYCIN A. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does KANAMYCIN\KANAMYCIN A Cause?

Drug resistance (38) Tuberculosis (21) Vomiting (21) Anaemia (18) Arthralgia (15) Nausea (15) Electrocardiogram qt prolonged (14) Nephropathy toxic (12) Off label use (12) Asthenia (9)

What Other Drugs Cause Neuropathy peripheral?

LENALIDOMIDE (10,215) BORTEZOMIB (4,067) OXALIPLATIN (3,662) DEXAMETHASONE (3,543) PACLITAXEL (3,508) LEVOFLOXACIN (2,619) CIPROFLOXACIN (2,607) FLUOROURACIL (2,605) CYCLOPHOSPHAMIDE (2,565) POMALIDOMIDE (2,382)

Which KANAMYCIN\KANAMYCIN A Alternatives Have Lower Neuropathy peripheral Risk?

KANAMYCIN\KANAMYCIN A vs KARDEGIC KANAMYCIN\KANAMYCIN A vs KEPPRA KANAMYCIN\KANAMYCIN A vs KETAMINE KANAMYCIN\KANAMYCIN A vs KETOCONAZOLE KANAMYCIN\KANAMYCIN A vs KETOPROFEN

Related Pages

KANAMYCIN\KANAMYCIN A Full Profile All Neuropathy peripheral Reports All Drugs Causing Neuropathy peripheral KANAMYCIN\KANAMYCIN A Demographics